Dow Up0.15% Nasdaq Up0.21%

Ultragenyx Pharmaceutical Inc. (RARE)

-NasdaqGS
55.96 0.38(0.67%) Sep 17, 4:00PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.46-0.52-2.08-2.13
No. of Analysts3.003.004.004.00
Low Estimate-0.51-0.59-2.32-2.21
High Estimate-0.43-0.46-1.93-1.90
Year Ago EPSN/A-4.98-14.87-2.08
Revenue EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. EstimateNaNNaNNaNNaN
No. of Analysts2244
Low EstimateNaNNaNNaNNaN
High EstimateNaNNaNNaNNaN
Year Ago SalesNaNNaNNaNNaN
Sales Growth (year/est)N/AN/AN/AN/A
Earnings HistoryDec 13Mar 14Jun 14
EPS EstN/A-0.38-0.37-0.42
EPS ActualN/A-4.98-0.85-0.45
DifferenceN/A-4.60-0.48-0.03
Surprise %N/A-1,210.50%-129.70%-7.10%
EPS TrendsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.46-0.52-2.08-2.13
7 Days Ago-0.46-0.52-2.08-2.13
30 Days Ago-0.46-0.52-2.06-2.11
60 Days Ago-0.46-0.52-2.07-2.13
90 Days Ago-0.50-0.57-2.07-2.10
EPS RevisionsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstRAREIndustrySectorS&P 500
Current Qtr.N/AN/A-75.20%13.50%
Next Qtr.89.60%N/A-64.20%23.70%
This Year86.00%N/A45.20%7.70%
Next Year-2.40%N/A-92,631,570.50%13.00%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A21.77%16.15%10.13%
Price/Earnings (avg. for comparison categories)-27.752.636.085.83
PEG Ratio (avg. for comparison categories)N/A29.648.520.88
Currency in USD.